The other studies proved that immune cells, especially T cells of CLL patients, show higher expression of various inhibitory receptors, such as Tim-3, as well as PD-1 and CTLA4, which constitute immune checkpoints eventually leading to T cell depletion [30,45,46,47]. This evidence concerns the gene HAVCR2 and B-cell chronic lymphocytic leukemia.